Sign up for Updates
(The Daily Californian) In conjunction with the Jan. 1 California Senate Bill 367, which aims to end opioid overdoses at public colleges and universities in the state by requiring them to keep opioid reversal drugs on campus, the California Department of Public Health, or CDPH, has attempted to increase access to Naloxone, one such reversal drug.
According to CDPH, data indicates that there have been around 6,843 deaths related to opioid overdose in 2021, with around 84% of those deaths related to fentanyl.
The bill, also known as the Campus Opioid Safety Act, requires community college districts, California State Universities and the UC system to provide a combination of educational information and reversal medications.